資源描述:
《對(duì)HBsAg和抗-HCVELISA篩查陽(yáng)性獻(xiàn)血者進(jìn)行確認(rèn)試》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫(kù)。
1、維普資訊http://www.cqvip.com第l5卷第12期中國(guó)現(xiàn)代醫(yī)學(xué)雜志V0I.15NO.12ChinaJournalofModemMedicineJun.20052005年6月文章編號(hào):1005—8982(2005)12—1885—03對(duì)HBsAg和抗一HCVELISA篩查陽(yáng)性獻(xiàn)血者進(jìn)行確認(rèn)試驗(yàn)分析歐陽(yáng)玲,李雪麗,黃呈輝,黃建國(guó),黃守明,黎淦平(深圳市寶安區(qū)血站,廣東深圳518101)摘要:目的探討對(duì)HBsAg和抗一HCVELISA篩查陽(yáng)性獻(xiàn)血者進(jìn)行確認(rèn)試驗(yàn)分析的意義。方法分別采用中和試驗(yàn)對(duì)ELISA檢測(cè)HBsAg陽(yáng)性獻(xiàn)血者和重組免疫印記試驗(yàn)(RIBA)對(duì)抗一HCV陽(yáng)性獻(xiàn)血者
2、進(jìn)行確認(rèn)檢測(cè)。并對(duì)確認(rèn)試驗(yàn)陰性獻(xiàn)血者進(jìn)行NAT檢測(cè)。結(jié)果38693份獻(xiàn)血者中,ELISA篩查出HBsAg和抗一HCV陽(yáng)性分別為381(O.98%)份和173(O。45%)份。在ELISA篩查出的381份HBsAg陽(yáng)性獻(xiàn)血者中,經(jīng)中和試驗(yàn)確認(rèn)HBsAg陽(yáng)性352份,29份為陰性;173份抗一Hcv陽(yáng)性獻(xiàn)血者中,RIBA試驗(yàn)確認(rèn)79份陽(yáng)性,59份陰性,35份為可疑;29份中和試驗(yàn)確認(rèn)HI3sAg陰性標(biāo)本和94份RIBA確認(rèn)抗一HCV陰性或可疑的標(biāo)本,NAT檢測(cè)HBVDNA和HCVRNA均為陰性。結(jié)論對(duì)獻(xiàn)血者進(jìn)行FlA3sAg和抗一HCV確認(rèn)試驗(yàn)?zāi)軌虮苊饧訇?yáng)性結(jié)果的發(fā)生,有利于保護(hù)獻(xiàn)血者的利
3、益和推動(dòng)志愿無(wú)償獻(xiàn)血事業(yè)的開展。關(guān)鍵詞:乙型肝炎表面抗原;丙型肝炎病毒抗體:中和試驗(yàn);重組免疫印記試驗(yàn)中圖分類號(hào):R446.61文件標(biāo)識(shí)碼:BAnalysisofconfirmatorytestonblooddonorsforHBsAgandanti-HCVpositivebyELISAOUYANGLing,LIXue-li,HUANGCheng—hui,HUANGJian—guo,HUANGShou—ming,LIGan-ping(ShenzhenBaoanBloodCenter,Shenzhen,Guangdong518101,P.R.China)Abstract:【0bjecti
4、ve】ToevaluatetheimportanceofconfirmatorytestfordetectingHBsAgandanti-HCVinblooddonors.【Methods】ThesamplesofHBsAgpositivebyELISAwereconfirmedbyneutralizationtestandthesamplesofanti—HCVpositivewereconfirmedbyRIBA3.0、Thenegativesamplesofconfirmatorytestwerefurtherdetectedbynucleicacidamplificationt
5、est(NAT).【Results】Among38693samplesfromblooddonors,38I(o.98%)sampleswereHBsAgpositiveandI73(O.45%)sampleswereanti-HCVpositivebyELISA.Of38IHBsAgpositivesamplesbyELISA,352sampleswerepositiveforHBsAgand29sampleswerenegativebyneutralizationtest.Of173anti—HCVpositivesamplesbyELISA,79sampleswerepositi
6、veforanti-HCV,35samp~swereand59sampleswerenegativebyRIBA.29HBsAg—negativeand94anti-HCV-indeterminateornegativesamplesbyconfirmatorytestwasHBV—DNAnegativeorHCV—RNAnegativebyNAT.【Conclusion】TheresultshowsthatHBsAgandanti—HCVfalse—positivesamplesshouldbeavoidedbyconfirmatorytest.ItCanprotectblooddo
7、norsandimpelvoluntarynonremunerateddonation.Keywords:HBsAg;anti—HCV;neutralizationtest;RIBA為保證血液質(zhì)量,減少輸血傳播疾病發(fā)生,從響對(duì)血液檢測(cè)結(jié)果的判斷。我們從2001年10月1997年起,我站采用國(guó)產(chǎn)試劑對(duì)血液進(jìn)行初檢,進(jìn)起,開展了對(duì)ELISA檢測(cè)HBsAg和/或抗一HCV陽(yáng)口試劑進(jìn)行復(fù)檢的檢測(cè)模式。為避免由于不同試劑性的獻(xiàn)血者進(jìn)行確認(rèn)試驗(yàn)工作。現(xiàn)將結(jié)